PLA2G7 anticorps (AA 200-228)
Aperçu rapide pour PLA2G7 anticorps (AA 200-228) (ABIN2843066)
Antigène
Voir toutes PLA2G7 (Lp-PLA2) AnticorpsReactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Épitope
- AA 200-228
-
Purification
- This antibody is purified through a protein A column, followed by peptide affinity purification.
-
Immunogène
- This PLA2G7 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 200-228 amino acids from the Central region of human PLA2G7.
-
Isotype
- Ig Fraction
-
-
-
-
Indications d'application
- WB: 1:2000. WB: 1:1000. IHC-P: 1:25. IHC-P: 1:25. IHC-P: 1:10~50. FC: 1:25
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- Purified polyclonal antibody supplied in PBS with 0.09 % (W/V) sodium azide.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- 4 °C,-20 °C
-
Stockage commentaire
- Maintain refrigerated at 2-8 °C for up to 6 months. For long term storage store at -20 °C in small aliquots to prevent freeze-thaw cycles.
-
Date de péremption
- 6 months
-
-
-
: "Autotaxin Derived From Lipoprotein(a) and Valve Interstitial Cells Promotes Inflammation and Mineralization of the Aortic Valve." dans: Circulation, (2015) (PubMed).
-
-
- PLA2G7 (Lp-PLA2) (Lipoprotein-Associated phospholipase A2 (Lp-PLA2))
-
Autre désignation
- PLA2G7
-
Sujet
- The protein encoded by this gene is a secreted enzyme that catalyzes the degradation of platelet-activating factor to biologically inactive products. Defects in this gene are a cause of platelet-activating factor acetylhydrolase deficiency.
-
Poids moléculaire
- 50077
-
ID gène
- 7941
-
NCBI Accession
- NP_001161829, NP_005075
-
UniProt
- Q13093
-
Pathways
- Peptide Hormone Metabolism
Antigène
-